# Cannabis Dispensary Owner Raises Alarm on 7-OH Product Safety > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/7-oh-product-safety-concerns-cannabis-dispensaries/ > **Published:** 2026-03-26T11:04:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:37:56-04:00 > **Clinical Summary:** Explore 7-OH product safety concerns as cannabis dispensary owners warn about unregulated kratom-derived opioids posing risks to patients. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic KratomOpioid SafetyProduct QualityRegulationPatient Safety Why This Matters 7-OH (7-hydroxymitragynine) is a potent opioid receptor agonist derived from kratom that’s being marketed in unregulated products with minimal safety data. This represents a significant clinical concern as patients may unknowingly consume a substance with opioid-like effects and addiction potential while believing they’re using a benign botanical product. Clinical Summary 7-hydroxymitragynine is a kratom-derived alkaloid with high affinity for mu-opioid receptors, demonstrating potency comparable to morphine in preclinical studies. Unlike regulated cannabis products, 7-OH products lack standardized dosing, quality controls, or clinical safety data. The substance can cause respiratory depression, dependence, and withdrawal symptoms similar to traditional opioids. Dispensary operators are raising concerns about these unregulated products being sold alongside or confused with cannabis products. Dr. Caplan’s Take “This highlights a broader problem with the supplement and unregulated botanical space—patients think ‘natural’ means safe, but 7-OH has real opioid pharmacology without opioid-level oversight. We need clear product labeling and [patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/) to prevent unintended opioid exposure.” Clinical Perspective 🧠 Clinicians should ask patients specifically about kratom-derived products and 7-OH use, as patients may not volunteer this information or recognize it as pharmacologically active. Monitor for signs of opioid tolerance or withdrawal in patients using these products. Consider this in differential diagnosis for unexplained sedation, respiratory depression, or withdrawal symptoms. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20dispensary%20owner%20warns%20Moses%20Lake%20council%20about%207-OH%20products%2C%20urges%20lo...%20%40drcaplan&url=https%3A//www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20dispensary%20owner%20warns%20Moses%20Lake%20council%20about%207-OH%20products%2C%20urges%20lo...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html](https://www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html) Table of Contents - [FAQ](#FAQ)[What is kratom and why is it clinically relevant?](#What_is_kratom_and_why_is_it_clinically_relevant) - [What are the main safety concerns with kratom products?](#What_are_the_main_safety_concerns_with_kratom_products) - [How is kratom currently regulated?](#How_is_kratom_currently_regulated) - [What should clinicians know about kratom product quality?](#What_should_clinicians_know_about_kratom_product_quality) - [Why is this considered a notable clinical development?](#Why_is_this_considered_a_notable_clinical_development) - [Related](#Related) ## FAQ #### What is kratom and why is it clinically relevant? Kratom is a plant-based substance that has gained attention for its potential effects on opioid use and [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/). This clinical update indicates emerging findings regarding kratom that warrant close monitoring by [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### What are the main safety concerns with kratom products? The key safety concerns include opioid-related risks and product quality issues. Healthcare providers should be aware of potential interactions and variable product standards in the current unregulated market. #### How is kratom currently regulated? Kratom exists in a complex regulatory environment with varying state and federal oversight. The regulatory status continues to evolve as more research emerges about its safety and efficacy profile. #### What should clinicians know about kratom product quality? Product quality remains a significant concern due to lack of standardization in the kratom market. Clinicians should be aware that products may vary widely in potency, purity, and contamination levels. #### Why is this considered a notable clinical development? This update represents emerging findings or policy developments that healthcare providers should monitor closely. The clinical relevance rating suggests this information could impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions and safety considerations. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis dispensary owner warns Moses Lake council about 7-OH products, urges local action”, “url”: “https://www.yoursourceone.com/columbia_basin/cannabis-dispensary-owner-warns-moses-lake-council-about-7-oh-products-urges-local-action/article_abedef40-1565-4932-b53d-4fb3a4d46f70.html”, “datePublished”: “2026-03-26T06:48:50Z”, “about”: “cannabis dispensary owner warns moses lake”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Maine warns of unsafe pesticides in some cannabis vapes](https://cedclinic.com/maine-warns-of-unsafe-pesticides-in-some-cannabis-vapes/) Learn about safety concerns in cannabis products, including pesticide contamination risks that parallel issues with unregulated 7-OH products. [Read More](https://cedclinic.com/maine-warns-of-unsafe-pesticides-in-some-cannabis-vapes/) Operation 420 raids uncover illegal THC sales in North Georgia Explore enforcement actions against illegal cannabis sales, highlighting the importance of regulation in protecting [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/). Learn More [What are fentanyl, synthetic cannabinoids and why is Malaysia sounding the alarm?](https://cedclinic.com/what-are-fentanyl-synthetic-cannabinoids-and-why-is-malaysia-sounding-the-alarm/) Understand the risks of synthetic substances in the cannabis market, similar to concerns raised about 7-OH products. [Discover More](https://cedclinic.com/what-are-fentanyl-synthetic-cannabinoids-and-why-is-malaysia-sounding-the-alarm/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).